Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
8 | 37965106 | non coding transcript exon variant | C/G | snv | 7.4E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
8 | 37965106 | non coding transcript exon variant | C/G | snv | 7.4E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
8 | 37965106 | non coding transcript exon variant | C/G | snv | 7.4E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
8 | 37965106 | non coding transcript exon variant | C/G | snv | 7.4E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
8 | 37965106 | non coding transcript exon variant | C/G | snv | 7.4E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
8 | 37965106 | non coding transcript exon variant | C/G | snv | 7.4E-03 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||||
|
0.851 | 0.040 | 8 | 37966277 | missense variant | T/C | snv | 7.0E-06 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
0.851 | 0.040 | 8 | 37966277 | missense variant | T/C | snv | 7.0E-06 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
0.851 | 0.040 | 8 | 37966277 | missense variant | T/C | snv | 7.0E-06 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.851 | 0.040 | 8 | 37966277 | missense variant | T/C | snv | 7.0E-06 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | |||||||
|
8 | 37965417 | missense variant | G/C | snv | 6.7E-06 |
|
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2005 | 2005 | |||||||||
|
8 | 37966397 | missense variant | C/T | snv | 8.5E-06 |
|
Nutritional and Metabolic Diseases; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
0.578 | 0.640 | 8 | 37966280 | missense variant | A/G | snv | 0.11 | 9.2E-02 |
|
Mental Disorders | 0.010 | < 0.001 | 1 | 2012 | 2012 | ||||||
|
0.578 | 0.640 | 8 | 37966280 | missense variant | A/G | snv | 0.11 | 9.2E-02 |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||||
|
0.578 | 0.640 | 8 | 37966280 | missense variant | A/G | snv | 0.11 | 9.2E-02 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 1997 | 1997 | ||||||
|
0.578 | 0.640 | 8 | 37966280 | missense variant | A/G | snv | 0.11 | 9.2E-02 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2004 | 2004 | ||||||
|
0.578 | 0.640 | 8 | 37966280 | missense variant | A/G | snv | 0.11 | 9.2E-02 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||||
|
0.578 | 0.640 | 8 | 37966280 | missense variant | A/G | snv | 0.11 | 9.2E-02 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2004 | 2004 | ||||||
|
0.578 | 0.640 | 8 | 37966280 | missense variant | A/G | snv | 0.11 | 9.2E-02 |
|
Mental Disorders | 0.010 | < 0.001 | 1 | 2012 | 2012 | ||||||
|
0.578 | 0.640 | 8 | 37966280 | missense variant | A/G | snv | 0.11 | 9.2E-02 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
|
0.578 | 0.640 | 8 | 37966280 | missense variant | A/G | snv | 0.11 | 9.2E-02 |
|
Endocrine System Diseases | 0.010 | < 0.001 | 1 | 2000 | 2000 | ||||||
|
0.578 | 0.640 | 8 | 37966280 | missense variant | A/G | snv | 0.11 | 9.2E-02 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.010 | 1.000 | 1 | 2004 | 2004 | ||||||
|
0.578 | 0.640 | 8 | 37966280 | missense variant | A/G | snv | 0.11 | 9.2E-02 |
|
Digestive System Diseases; Neoplasms; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
|
0.578 | 0.640 | 8 | 37966280 | missense variant | A/G | snv | 0.11 | 9.2E-02 |
|
Digestive System Diseases; Neoplasms; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||||
|
0.578 | 0.640 | 8 | 37966280 | missense variant | A/G | snv | 0.11 | 9.2E-02 |
|
Behavior and Behavior Mechanisms | 0.010 | 1.000 | 1 | 2012 | 2012 |